AbbVie braves Humira LOE, remains confident in long-term growth R&D, Therapeutics In a fireside chat at the 41st J.P. Morgan Healthcare Conference in San Francisco, CEO Rick Gonzalez said AbbVie is well-positioned for continued growth. Read more January 11, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2021/06/Migraines-Be-Gone-AbbVie’s-Atopant-Reduces-Headache-Frequency-and-Severity-BioSpace-6-3-21.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-01-11 08:51:312023-01-11 08:54:15AbbVie braves Humira LOE, remains confident in long-term growth
